For research use only. Not for therapeutic Use.
Venlafaxine(CAT: I005540) is a serotonin-norepinephrine reuptake inhibitor (SNRI) widely utilized in neurological and psychiatric research. By inhibiting the reuptake of serotonin and norepinephrine, it enhances neurotransmitter availability in the synaptic cleft, making it effective for studying the mechanisms underlying mood regulation and pain perception. Venlafaxine is primarily explored for its therapeutic potential in managing major depressive disorder, anxiety disorders, and neuropathic pain. Researchers leverage its dual action to investigate novel approaches for treating mental health conditions. With its well-characterized pharmacological profile, Venlafaxine remains a valuable tool for advancing preclinical and clinical studies in psychopharmacology.
| CAS Number | 93413-69-5 |
| Molecular Formula | C17H27NO2 |
| Purity | ≥95% |
| Target | Serotonin Transporter |
| Solubility | DMSO 55.5 mg/mL (176 mM); Water 55.5 mg/mL (176 mM) |
| Storage | -20°C |
| Related CAS | 1020720-02-8 1062606-12-5 99300-78-4 |
| IUPAC Name | 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol |
| InChI | InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3 |
| InChIKey | PNVNVHUZROJLTJ-UHFFFAOYSA-N |
| SMILES | CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O |
